Highly Stable Silver(I) Complexes with Cyclen-Based Ligands Bearing Sulfide Arms: A Step Toward Silver-111 Labeled Radiopharmaceuticals

[Image: see text] With a half-life of 7.45 days, silver-111 (β(max) 1.04 MeV, E(γ) 245.4 keV [I(γ) 1.24%], E(γ) 342.1 keV [I(γ) 6.7%]) is a promising candidate for targeted cancer therapy with β(–) emitters as well as for associated SPECT imaging. For its clinical use, the development of suitable li...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosato, Marianna, Asti, Mattia, Dalla Tiezza, Marco, Orian, Laura, Häussinger, Daniel, Vogel, Raphael, Köster, Ulli, Jensen, Mikael, Andrighetto, Alberto, Pastore, Paolo, Marco, Valerio Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009516/
https://www.ncbi.nlm.nih.gov/pubmed/32658468
http://dx.doi.org/10.1021/acs.inorgchem.0c01405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009516/
https://www.ncbi.nlm.nih.gov/pubmed/32658468
http://dx.doi.org/10.1021/acs.inorgchem.0c01405

Ejemplares similares